ArticleCureus2025

Durable Response Following the Discontinuation of Immune Checkpoint Inhibitor Therapy in Advanced Non-small Cell Lung Cancer.

Taiyo Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.